Lv6
2504 积分 2022-08-12 加入
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
12小时前
已完结
Research Summary An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
12小时前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
12小时前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
14小时前
已完结
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
19小时前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
4天前
已完结
The present and future of bispecific antibodies for cancer therapy
4天前
已完结
Targeting RNA structures with small molecules
4天前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
4天前
已完结
Research Summary Phase 2 Trial of Tulisokibart for Ulcerative Colitis
4天前
已完结
皖公网安备34019202002308
